A disease that has terrified parrot breeders for the last few decades has been identified as a virus that is new to science. This discovery will allow scientists to find the source of this virus, to control its spread, develop a vaccine and to find a cure
For more than 30 years, a mysterious disease, known as proventricular dilatation disease (PDD), has sent chills of terror down the spines of bird lovers because it has been killing captive parrots. In fact, the Little Blue (Spix’s) Macaw, Cyanopsitta spixii, one of the world’s rarest and most endangered bird species, may have become extinct in the wild due to PDD. But fortunately for this species, and all other birds, it appears that the causative agent of PDD has finally been identified: a virus that is new to science.
According to a paper that will be published next week in the Journal of Virology, a large international team of research scientists, veterinarians and medical doctors identified this new agent as a type of bornavirus, a family of negative-stranded RNA viruses that typically cause encephalitis in horses and livestock. The team, led by postdoctoral fellow, Amy Kistler, has also designed a diagnostic test that detects this newly discovered virus, which they named Avian Bornavirus (ABV). Their diagnostic test will allow veterinarians to identify the source of this virus and to control the spread of this disease.
“This discovery has potentially solved a mystery that has been plaguing the avian veterinary community since the 1970s,” said molecular biologist Joseph DeRisi who, with his scientific partner, Don Ganem, MD, are both professors and Howard Hughes Medical Investigators at the University of California San Francisco.
The DeRisi Laboratory is part of the California Institute for Quantitative Biosciences, known as QB3. DeRisi Lab developed and patented the ViroChip, a high-throughput screening technology that uses a DNA microarray to test samples for viruses. (This interactive teaches how this technology works.) In 2003, the ViroChip made its scientific debut by recovering the virus that causes Severe Acute Respiratory Syndrome, or SARS. Currently, the ViroChip is used to diagnose and monitor the progression of human viral diseases, such as HIV/AIDS. In honor of this innovation, DeRisi was awarded the MacArthur “Genius” Award.
PDD, originally known by a variety of names such as “Macaw Wasting Disorder” or “Macaw Fading Syndrome,” was first described in 1978 in macaws that had been imported into the United States and Germany. Originally, it was thought that only macaws developed this disorder, but later it was found that more than 50 species of parrots along with members of five other avian taxonomic orders are susceptible. Due to the epidemiology patterns and other characteristics of the disorder, it was long suspected that PDD was caused by a virus.
PDD causes nervous system disorders in adult wild and captive psittacines and other birds throughout the world. It interferes with the ability to swallow and to digest food, causing the proventricular walls to become thin and fragile, leading to progressive weight loss and diminishing body condition. Often, these symptoms are accompanied by neurologic manifestations such as a lack of coordination or seizures. The disease typically results in premature death, usually due to proventricular rupture. According to the researchers, PDD is widely considered to be the greatest threat to captive breeding of parrots.
To identify this virus, two PDD case-control series were collected independently on different continents and analyzed using this pan-viral microarray technology, ViroChip. These microarrays revealed a bornavirus hybridization signature in 62.5% of the PDD cases but in none of the controls. Ultra high throughput sequencing was utilized to recover the complete viral genome sequence from one of the virus-positive PDD cases (figure 2A);
This genome was phylogenetically analyzed and found to fall within the Bornaviridae family. These analyses revealed a bornavirus-like genome organization for this agent while at the same time revealing it to be quite different from other known Bornaviridae (figure 2B);
This is the first time that a first full-length bornavirus genome has ever been cloned directly from avian tissue. Phylogenetic analysis of the nucleotide sequence of several genes from 16 individual ABV isolates found there are at least 5 distinct ABV genetic subgroups (figure 3A, B, C);
These studies clearly demonstrate the existence of a group of remarkably diverse avian bornaviruses that are the likely candidates in the search for an etiologic agent of PDD. Not only that, but this study identifies an avian reservoir for bornaviruses but reveals that the bornaviridae encompass an unexpectedly genetically diverse group of viral types.
These data are very promising but the next step that the team must take before they can conclusively prove that ABV is the causative agent of PDD is to satisfy Koch’s postulates. These postulates stipulate that the virus must be first be grown in a pure laboratory culture and second, that cultured virus must be used to experimentally infect healthy parrots, which then must manifest the typical symptoms of PDD. Last, after these parrots succumb to the disease, ABV must be isolated from these experimentally infected birds.
“This provides a very compelling lead in the longstanding search for a viral cause of PDD,” Ganem said. “With the development of molecular clones and diagnostic tests for ABV, we can now begin to explore both the epidemiology of the virus and how it is linked to the disease state.”
Kistler, A.L., Gancz, A., Clubb, S., Skewes-Cox, P., Fischer, K., Sorber, K., Chiu, C.Y., Lublin, A., Mechani, S., Farnoushi, Y., Greninger, A., Wen, C.C., Karlene, S.B., Ganem, D., DeRisi, J.L. (2008). Recovery of divergent avian bornaviruses from cases of proventricular dilatation disease: identification of a candidate etiologic agent. Journal of Virology, 5(1), 88 | doi:10.1186/1743–422X-5–88.
Originally published at scienceblogs.com on 4 August 2008.